PMC3564056_01
PMC3564056_02
PMC3564056_03
Effect of intravenous immunoglobulin (IVIG) and bortezomib on the donor specific antibodies (DSA) in both the original intended donor (red) and the KPD donor (green) in case 3.
nihms428135f1.jpg
PMC3564056_03_nihms428135f1.jpg
F1
IVIG in an attempt to lower high-strength HLA antibodies (Figure 1). In August 2010, after three cycles of plasmapheresis and bortezomib, a match from a 33-year-old, blood type A potential donor was identified in the KPD pool.
PMC3564056_04
PMC3564056_05